skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

PML/JCV

(Last updated:11/1/2012; last reviewed:11/1/2012)

PML/JCV
Member Financial Disclosure
Company Relationship
Cinque, Paola
San Raffaele Scientific Institute, Milan, Italy Abbott Advisory Board, Speaker’s Bureau
Astellas Advisory Board
Biogen Advisory Board, Consultant, Research Support
Boehringer Ingelheim
Advisory Board, Speaker’s Bureau
Bristol-Myers Squibb
Speaker’s Bureau
Elan Advisory Board
Gilead Speaker’s Bureau
GlaxoSmithKline
Advisory Board, Speaker’s Bureau
Janssen-Cilag
Advisory Board, Speaker’s Bureau
Johnson & Johnson
Consultant
Merck Speaker’s Bureau
Mundipharma
Research Support, Speaker’s Bureau
Pfizer Consultant
ViiV Healthcare
Advisory Board
Clifford, David
Washington University School of Medicine
Amgen Consultant
Biogen Consultant, Honoraria
Bristol-Myers Squibb
Advisory Board, Consultant
Drinker Biddle, Reath LLC
Advisory Board
Genetech Advisory Board, DSMB Member
Genzyme
DSMB Member
GlaxoSmithKline
Honoraria
Janssen Consultant
Millennium
Consultant, DSMB Member, Honoraria
Novartis Consultant, Research Support
Pfizer Consultant, DSMB Member
Marra, Christina
Washington University School of Medicine
Cempra Inc. Research Support
Miro, Jose M.

 
 
 
 
 
 
Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

 
 
 
 
 
 
Abbott Consultant, Honoraria, Speaker’s Bureau
Astellas Consultant
Boehringer Ingelheim
Speaker's Bureau
Bristol-Myers Squibb
Consultant, Honoraria, Research Support, Speaker’s Bureau
Cubist Advisory Board, Consultant, Honoraria, Research Support, Speaker’s Bureau
Fundacion Maximo Soriano Jimenez, Barcelona, Spain
Research Support
Gilead
Consultant, Honoraria, Speaker’s Bureau
GlaxoSmithKline
Honoraria, Speaker’s Bureau
Instituto de Salud Carlos III, Spanish Ministry of Health, Madrid, Spain
Research Support
Janssen-Cilag
Speaker’s Bureau
Merck Consultant, Speaker’s Bureau
NIH Research Support
Novartis Advisory Board, Consultant, Honoraria, Research Support, Speaker’s Bureau
Pfizer Consultant, Speaker’s Bureau
Roche Speaker’s Bureau
Schering-Plough
Speaker’s Bureau
Theravance Consultant, Speaker’s Bureau
ViiV Healthcare
Honoraria, Speaker’s Bureau
Price, Richard*


University of California San Francisco


Abbott Honoraria, Travel Support
Merck Research Support
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.